Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122186 · ClinicalTrials.gov registry record · NA
Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
A NA study, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
NCT01122186 is a NA study that has completed, run by Hunter College of City University of New York. The registered enrollment target is 210 participants.
The verdict
NCT01122186, a NA study, has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
Study Summary
The primary aim is to test an innovative 8-session intervention, based on Motivational Interviewing and Cognitive Behavioral Skills-Training for the co-occurrence of methamphetamine use and highly active antiretroviral therapy (HAART) non-adherence among methamphetamine using HIV+ MSM in NYC, compared to an 8-session educational (ED) condition. Participants in the intervention condition will report greater reductions in the number of days of methamphetamine use and viral load, and greater increases in CD4 counts and self-reported and objectively measured adherence than those in the education condition.
Interventions
- BEHAVIORAL Motivational Interviewing + Cognitive Behavioral Skills Training
- BEHAVIORAL Education Attention Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01122186
The ClinicalTrials.gov registry entry for NCT01122186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hunter College of City University of New York, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing + Cognitive Behavioral Skills Training is the first listed.
NCT01122186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01122186 about?
NCT01122186 is a clinical study titled "Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)". The primary aim is to test an innovative 8-session intervention, based on Motivational Interviewing and Cognitive Behavioral Skills-Training for the co-occurrence of methamphetamine use and highly active antiretroviral therapy (HAART) non-adherence among methamphetamine using HIV+ MSM in NYC, compar...
What is the current status of trial NCT01122186?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2007-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01122186?
The interventions under investigation include: Motivational Interviewing + Cognitive Behavioral Skills Training (BEHAVIORAL), Education Attention Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01122186?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.